Anzeige
Mehr »
Login
Mittwoch, 08.07.2020 Börsentäglich über 12.000 News von 632 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 897518 ISIN: US62855J1043 Ticker-Symbol: MYD 
Tradegate
07.07.20
10:58 Uhr
10,400 Euro
-0,100
-0,95 %
1-Jahres-Chart
MYRIAD GENETICS INC Chart 1 Jahr
5-Tage-Chart
MYRIAD GENETICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
10,10010,40007.07.
10,20010,30007.07.

Aktuelle News zur MYRIAD GENETICS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiMyriad Genetics, OptraHEALTH Partner to Offer Cancer Knowledge1
DiMyriad Genetics, Inc.: Myriad Announces New Studies Validating the Ability of Myriad's riskScore Test to Modify Breast Cancer Risk Prediction-
MoMyriad Genetics Rides on EndoPredict Amid Coronavirus Crisis4
MYRIAD GENETICS Aktie jetzt für 0€ handeln
MoMyriad Partners OptraHEALTH For AI-Based Information Tool Gene759WASHINGTON (dpa-AFX) - Molecular diagnostics company Myriad Genetics, Inc. (MYGN) announced Monday a new collaboration with AI platform OptraHEALTH to implement a cognitive ChatBOT named Gene...
► Artikel lesen
DoMyriad Genetics Unveils New Home DNA Sample Collection Kit2
01.07.Myriad Genetics launches GeneSight home collection kit5
29.06.Myriad Genetics' myPath Melanoma Proved Superior Per New Study4
25.06.Myriad Genetics, Inc.: New Study Demonstrates the Ability of myPath Melanoma to Accurately Classify Lesions Ruled Indeterminate by Standard Pathological ...6
22.06.BRIEF-Camber Capital Management Lp Reports 5.37% Passive Stake In Myriad Genetics8
17.06.Myriad Genetics' Prolaris Receives Favorable Coverage Policies9
15.06.Myriad Genetics, Inc.: Myriad Announces New Favorable Coverage Policies for Prolaris from Three New Commercial Health Plans Including Major National Provider10
11.06.Here's Why Myriad Genetics Is Tumbling Today39
11.06.Myriad Genetics tumbles on continued COVID-19 pressures17
09.06.Myriad Genetics' Test Better Predicts Drug Levels Per Study8
08.06.Myriad Genetics, Inc.: New Study Demonstrates GeneSight Psychotropic Better Predicts Blood Drug Levels When Compared to Single-Gene Testing3
04.06.Myriad: EndoPredict Predicts Response To Neoadjuvant Chemotherapy And Endocrine Therapy218WASHINGTON (dpa-AFX) - Myriad Genetics Inc. (MYGN) said a prospective study demonstrated that the EndoPredict test predicts which patients with ER+, HER2- early-stage breast cancer will benefit...
► Artikel lesen
04.06.BRIEF-Myriad Genetics Reports Publication Of Prospective Study Of Endopredict Test2
04.06.Myriad Genetics, Inc.: Myriad Genetics Announces Publication of a Prospective Clinical Study of the EndoPredict Test in Women with Early-Stage Breast ...2
29.05.Myriad Genetics, Inc.: Myriad Presents New Data at ASCO Validating the Ability of riskScore to Provide Personalized Breast Cancer Risk Information to ...3
28.05.BRIEF-Myriad Genetics - Board Approved Increase In Size Of Board To Nine Members-
Seite:  Weiter >>
81 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,2